Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Prostatic dysplasia
ADR ID BADD_A06641
ADR Hierarchy
21      Reproductive system and breast disorders
21.04      Prostatic disorders (excl infections and inflammations)
21.04.01      Prostatic signs, symptoms and disorders NEC
21.04.01.007      Prostatic dysplasia
Description A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The neoplasia takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer. [MeSH]
MedDRA Code 10071019
MeSH ID D019048
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
PIN - prostatic intraepithelial neoplasia | Prostatic intraepithelial neoplasia | High grade prostatic intraepithelial neoplasia | Low grade prostatic intraepithelial neoplasia | Prostatic dysplasia | Atypical small acinar proliferation of prostate | Prostatic Intraepithelial Neoplasia | Neoplasia, Prostatic Intraepithelial | Intraepithelial Neoplasia, Prostatic | Prostatic Intraepithelial Neoplasias | Prostatic Intraepithelial Neoplasms | Intraepithelial Neoplasm, Prostatic | Intraepithelial Neoplasms, Prostatic | Neoplasm, Prostatic Intraepithelial | Neoplasms, Prostatic Intraepithelial | Prostatic Intraepithelial Neoplasm | Intraepithelial Prostatic Neoplasia | Intraepithelial Prostatic Neoplasias | Neoplasia, Intraepithelial Prostatic | Prostatic Neoplasia, Intraepithelial
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00898Finasteride0.000045%
BADD_D01913Ranitidine0.000050%
BADD_D02105Tacrolimus0.000297%
BADD_D02170Testosterone--
BADD_D02174Testosterone undecanoate--
The 1th Page    1    Total 1 Pages